Literature DB >> 20385358

ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading.

Paul Mak1, Irwin Leav, Bryan Pursell, Donggoo Bae, Xiaofang Yang, Cherie A Taglienti, Lindsey M Gouvin, Vishva M Sharma, Arthur M Mercurio.   

Abstract

High Gleason grade prostate carcinomas are aggressive, poorly differentiated tumors that exhibit diminished estrogen receptor beta (ERbeta) expression. We report that a key function of ERbeta and its specific ligand 5alpha-androstane-3beta,17beta-diol (3beta-adiol) is to maintain an epithelial phenotype and repress mesenchymal characteristics in prostate carcinoma. Stimuli (TGF-beta and hypoxia) that induce an epithelial-mesenchymal transition (EMT) diminish ERbeta expression, and loss of ERbeta is sufficient to promote an EMT. The mechanism involves ERbeta-mediated destabilization of HIF-1alpha and transcriptional repression of VEGF-A. The VEGF-A receptor neuropilin-1 drives the EMT by promoting Snail1 nuclear localization. Importantly, this mechanism is manifested in high Gleason grade cancers, which exhibit significantly more HIF-1alpha and VEGF expression, and Snail1 nuclear localization compared to low Gleason grade cancers. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20385358      PMCID: PMC2881822          DOI: 10.1016/j.ccr.2010.02.030

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  72 in total

1.  Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta.

Authors:  G G Kuiper; B Carlsson; K Grandien; E Enmark; J Häggblad; S Nilsson; J A Gustafsson
Journal:  Endocrinology       Date:  1997-03       Impact factor: 4.736

2.  Activation of phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinoma invasion.

Authors:  L M Shaw; I Rabinovitz; H H Wang; A Toker; A M Mercurio
Journal:  Cell       Date:  1997-12-26       Impact factor: 41.582

3.  Estrogen receptor-beta messenger ribonucleic acid ontogeny in the prostate of normal and neonatally estrogenized rats.

Authors:  G S Prins; M Marmer; C Woodham; W Chang; G Kuiper; J A Gustafsson; L Birch
Journal:  Endocrinology       Date:  1998-03       Impact factor: 4.736

Review 4.  The novel estrogen receptor-beta subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens.

Authors:  G G Kuiper; J A Gustafsson
Journal:  FEBS Lett       Date:  1997-06-23       Impact factor: 4.124

5.  Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.

Authors:  Dennis R Compton; Shubin Sheng; Kathryn E Carlson; Natalie A Rebacz; In Young Lee; Benita S Katzenellenbogen; John A Katzenellenbogen
Journal:  J Med Chem       Date:  2004-11-18       Impact factor: 7.446

6.  Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.

Authors:  S Soker; S Takashima; H Q Miao; G Neufeld; M Klagsbrun
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

7.  Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer.

Authors:  Simona Nanni; Valentina Benvenuti; Annalisa Grasselli; Carmen Priolo; Aurora Aiello; Stefania Mattiussi; Claudia Colussi; Vittoria Lirangi; Barbara Illi; Manuela D'Eletto; Anna Maria Cianciulli; Michele Gallucci; Piero De Carli; Steno Sentinelli; Marcella Mottolese; Paolo Carlini; Lidia Strigari; Stephen Finn; Elke Mueller; Giorgio Arcangeli; Carlo Gaetano; Maurizio C Capogrossi; Raffaele Perrone Donnorso; Silvia Bacchetti; Ada Sacchi; Alfredo Pontecorvi; Massimo Loda; Antonella Farsetti
Journal:  J Clin Invest       Date:  2009-04-13       Impact factor: 14.808

8.  miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells.

Authors:  Dejuan Kong; Yiwei Li; Zhiwei Wang; Sanjeev Banerjee; Aamir Ahmad; Hyeong-Reh Choi Kim; Fazlul H Sarkar
Journal:  Stem Cells       Date:  2009-08       Impact factor: 6.277

9.  Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion.

Authors:  Yadi Wu; Jiong Deng; Piotr G Rychahou; Suimin Qiu; B Mark Evers; Binhua P Zhou
Journal:  Cancer Cell       Date:  2009-05-05       Impact factor: 31.743

10.  Intratissular androgens in benign prostatic hyperplasia and prostatic cancer.

Authors:  K D Voigt; W Bartsch
Journal:  J Steroid Biochem       Date:  1986-11       Impact factor: 4.292

View more
  185 in total

1.  Another road leads to HIF-1 activation: implications for prostate cancer progression.

Authors:  Yao Dai; Kyungmi Bae; Dietmar W Siemann
Journal:  Asian J Androl       Date:  2011-11-21       Impact factor: 3.285

2.  [Antiandrogen strategies in prostate cancer: reconstitution of oestrogen receptor beta].

Authors:  P Thelen; A Strauss; M Stettner; S Kaulfuss; R-H Ringert; H Loertzer
Journal:  Urologe A       Date:  2010-09       Impact factor: 0.639

Review 3.  Estrogen signaling via estrogen receptor {beta}.

Authors:  Chunyan Zhao; Karin Dahlman-Wright; Jan-Åke Gustafsson
Journal:  J Biol Chem       Date:  2010-10-18       Impact factor: 5.157

Review 4.  Hypoxia-inducible factors in physiology and medicine.

Authors:  Gregg L Semenza
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582

5.  VEGF/neuropilin-2 regulation of Bmi-1 and consequent repression of IGF-IR define a novel mechanism of aggressive prostate cancer.

Authors:  Hira Lal Goel; Cheng Chang; Bryan Pursell; Irwin Leav; Stephen Lyle; Hualin Simon Xi; Chung-Cheng Hsieh; Helty Adisetiyo; Pradip Roy-Burman; Ilsa M Coleman; Peter S Nelson; Robert L Vessella; Roger J Davis; Stephen R Plymate; Arthur M Mercurio
Journal:  Cancer Discov       Date:  2012-07-09       Impact factor: 39.397

Review 6.  Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia.

Authors:  Muhammad Zaeem Noman; Meriem Hasmim; Yosra Messai; Stéphane Terry; Claudine Kieda; Bassam Janji; Salem Chouaib
Journal:  Am J Physiol Cell Physiol       Date:  2015-08-26       Impact factor: 4.249

Review 7.  Local endocrine, paracrine and redox signaling networks impact estrogen and androgen crosstalk in the prostate cancer microenvironment.

Authors:  Melanie J Grubisha; Donald B DeFranco
Journal:  Steroids       Date:  2013-02-01       Impact factor: 2.668

8.  The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer.

Authors:  Vasundhra Kashyap; Shafqat Ahmad; Emeli M Nilsson; Leszek Helczynski; Sinéad Kenna; Jenny Liao Persson; Lorraine J Gudas; Nigel P Mongan
Journal:  Mol Oncol       Date:  2013-01-19       Impact factor: 6.603

9.  Erb-041, an estrogen receptor-β agonist, inhibits skin photocarcinogenesis in SKH-1 hairless mice by downregulating the WNT signaling pathway.

Authors:  Sandeep C Chaudhary; Tripti Singh; Sarang S Talwelkar; Ritesh K Srivastava; Aadithya Arumugam; Zhiping Weng; Craig A Elmets; Farrukh Afaq; Levy Kopelovich; Mohammad Athar
Journal:  Cancer Prev Res (Phila)       Date:  2013-11-11

10.  Estrogen receptor β, a regulator of androgen receptor signaling in the mouse ventral prostate.

Authors:  Wan-Fu Wu; Laure Maneix; Jose Insunza; Ivan Nalvarte; Per Antonson; Juha Kere; Nancy Yiu-Lin Yu; Virpi Tohonen; Shintaro Katayama; Elisabet Einarsdottir; Kaarel Krjutskov; Yu-Bing Dai; Bo Huang; Wen Su; Margaret Warner; Jan-Åke Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.